Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Je-Seong Won and Avtar Singh.
Connection Strength

3.343
  1. S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion. Brain Res. 2015 Oct 22; 1624:359-369.
    View in: PubMed
    Score: 0.548
  2. Role of endogenous psychosine accumulation in oligodendrocyte differentiation and survival: implication for Krabbe disease. Brain Res. 2013 May 01; 1508:44-52.
    View in: PubMed
    Score: 0.462
  3. Protective role of S-nitrosoglutathione (GSNO) against cognitive impairment in rat model of chronic cerebral hypoperfusion. J Alzheimers Dis. 2013; 34(3):621-35.
    View in: PubMed
    Score: 0.457
  4. The involvement of glucose metabolism in the regulation of inducible nitric oxide synthase gene expression in glial cells: possible role of glucose-6-phosphate dehydrogenase and CCAAT/enhancing binding protein. J Neurosci. 2003 Aug 20; 23(20):7470-8.
    View in: PubMed
    Score: 0.239
  5. Vascular and immunopathological role of Asymmetric Dimethylarginine (ADMA) in Experimental Autoimmune Encephalomyelitis. Immunology. 2021 11; 164(3):602-616.
    View in: PubMed
    Score: 0.207
  6. Asymmetric dimethylarginine exacerbates cognitive dysfunction associated with cerebrovascular pathology. FASEB J. 2020 05; 34(5):6808-6823.
    View in: PubMed
    Score: 0.189
  7. Regulation of endothelial barrier integrity by redox-dependent nitric oxide signaling: Implication in traumatic and inflammatory brain injuries. Nitric Oxide. 2019 02 01; 83:51-64.
    View in: PubMed
    Score: 0.173
  8. Combination therapy of lovastatin and AMP-activated protein kinase activator improves mitochondrial and peroxisomal functions and clinical disease in experimental autoimmune encephalomyelitis model. Immunology. 2018 07; 154(3):434-451.
    View in: PubMed
    Score: 0.163
  9. Role of S-nitrosoglutathione mediated mechanisms in tau hyper-phosphorylation. Biochem Biophys Res Commun. 2015 Feb 27; 458(1):214-9.
    View in: PubMed
    Score: 0.132
  10. Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis. Biochem Biophys Res Commun. 2010 Sep 03; 399(4):487-91.
    View in: PubMed
    Score: 0.097
  11. Lactosylceramide: a lipid second messenger in neuroinflammatory disease. J Neurochem. 2007 Nov; 103 Suppl 1:180-91.
    View in: PubMed
    Score: 0.080
  12. Involvement of phospholipase A2 and lipoxygenase in lipopolysaccharide-induced inducible nitric oxide synthase expression in glial cells. Glia. 2005 Jul; 51(1):13-21.
    View in: PubMed
    Score: 0.068
  13. Dual role of cAMP in iNOS expression in glial cells and macrophages is mediated by differential regulation of p38-MAPK/ATF-2 activation and iNOS stability. Free Radic Biol Med. 2004 Dec 01; 37(11):1834-44.
    View in: PubMed
    Score: 0.065
  14. The role of neutral sphingomyelinase produced ceramide in lipopolysaccharide-mediated expression of inducible nitric oxide synthase. J Neurochem. 2004 Feb; 88(3):583-93.
    View in: PubMed
    Score: 0.062
  15. Neuroprotective effects of Alda-1 mitigate spinal cord injury in mice: involvement of Alda-1-induced ALDH2 activation-mediated suppression of reactive aldehyde mechanisms. Neural Regen Res. 2022 Jan; 17(1):185-193.
    View in: PubMed
    Score: 0.053
  16. Regulation of B cell functions by S-nitrosoglutathione in the EAE model. Redox Biol. 2021 09; 45:102053.
    View in: PubMed
    Score: 0.051
  17. GSNOR and ALDH2 alleviate traumatic spinal cord injury. Brain Res. 2021 05 01; 1758:147335.
    View in: PubMed
    Score: 0.050
  18. Detoxification of Reactive Aldehydes by Alda-1 Treatment Ameliorates Experimental Autoimmune Encephalomyelitis in Mice. Neuroscience. 2021 03 15; 458:31-42.
    View in: PubMed
    Score: 0.050
  19. S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis. Free Radic Biol Med. 2018 06; 121:57-68.
    View in: PubMed
    Score: 0.041
  20. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma. Redox Biol. 2015 Dec; 6:41-50.
    View in: PubMed
    Score: 0.034
  21. STAT3 regulation by S-nitrosylation: implication for inflammatory disease. Antioxid Redox Signal. 2014 Jun 01; 20(16):2514-27.
    View in: PubMed
    Score: 0.031
  22. Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death. Neurosci Lett. 2008 Aug 08; 440(3):260-4.
    View in: PubMed
    Score: 0.021
  23. Lovastatin inhibits amyloid precursor protein (APP) beta-cleavage through reduction of APP distribution in Lubrol WX extractable low density lipid rafts. J Neurochem. 2008 May; 105(4):1536-49.
    View in: PubMed
    Score: 0.020
  24. AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model. Nutr Metab (Lond). 2006 Aug 10; 3:31.
    View in: PubMed
    Score: 0.018
  25. Adenosine kinase inhibitor attenuates the expression of inducible nitric oxide synthase in glial cells. Neuropharmacology. 2005 Jan; 48(1):151-60.
    View in: PubMed
    Score: 0.016
  26. A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases. J Neurosci. 2004 Jun 30; 24(26):5942-54.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.